KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

AbCellera Biologics (ABCL) Interest & Investment Income: 2022-2023

Historic Interest & Investment Income for AbCellera Biologics (ABCL) over the last 2 years, with Dec 2023 value amounting to $11.0 million.

  • AbCellera Biologics' Interest & Investment Income rose 29.50% to $11.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $42.2 million, marking a year-over-year increase of 162.32%. This contributed to the annual value of $38.5 million for FY2024, which is 8.93% down from last year.
  • Latest data reveals that AbCellera Biologics reported Interest & Investment Income of $11.0 million as of Q4 2023, which was up 2.13% from $10.7 million recorded in Q3 2023.
  • In the past 5 years, AbCellera Biologics' Interest & Investment Income ranged from a high of $11.0 million in Q4 2023 and a low of $665,000 during Q1 2022.
  • Over the past 2 years, AbCellera Biologics' median Interest & Investment Income value was $9.1 million (recorded in 2022), while the average stood at $7.3 million.
  • Data for AbCellera Biologics' Interest & Investment Income shows a peak YoY skyrocketed of 1,367.52% (in 2023) over the last 5 years.
  • Over the past 2 years, AbCellera Biologics' Interest & Investment Income (Quarterly) stood at $8.5 million in 2022, then climbed by 29.50% to $11.0 million in 2023.
  • Its Interest & Investment Income stands at $11.0 million for Q4 2023, versus $10.7 million for Q3 2023 and $10.8 million for Q2 2023.